Cargando…

The Association of Serum Inflammatory Markers and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy

OBJECTIVES: Chemotherapy-induced neuroinflammation may contribute to cognitive dysfunction. Previously we found that serum omega-3 and omega-6 fatty acids were associated with inflammatory markers in a cohort of 60 women undergoing chemotherapy for breast cancer. The objective of this project was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zihan, Schnell, Patrick, Ormiston, Kate, Weinhold, Kellie, Kopec, Rachel, Lustberg, Maryam, Orchard, Tonya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193788/
http://dx.doi.org/10.1093/cdn/nzac052.025
_version_ 1784726552396693504
author Zhang, Zihan
Schnell, Patrick
Ormiston, Kate
Weinhold, Kellie
Kopec, Rachel
Lustberg, Maryam
Orchard, Tonya
author_facet Zhang, Zihan
Schnell, Patrick
Ormiston, Kate
Weinhold, Kellie
Kopec, Rachel
Lustberg, Maryam
Orchard, Tonya
author_sort Zhang, Zihan
collection PubMed
description OBJECTIVES: Chemotherapy-induced neuroinflammation may contribute to cognitive dysfunction. Previously we found that serum omega-3 and omega-6 fatty acids were associated with inflammatory markers in a cohort of 60 women undergoing chemotherapy for breast cancer. The objective of this project was to determine if serum inflammatory markers were correlated with self-reported cognitive assessments in these women. METHODS: Serum samples and data on self-reported cognitive function were collected from 60 women undergoing adjuvant chemotherapy for breast cancer at baseline, the fourth cycle of chemotherapy (C4), and 6 months after chemotherapy (6M). Serum inflammatory markers were analyzed using multiplex enzyme-linked immunoassay. Spearman's rank correlation was used to quantify the association between inflammatory markers and the Multifactorial Memory Questionnaire (MMQ) scores at baseline (n = 25), C4 (n = 18), and 6M (n = 18), as well as the Behavior Rating Inventory of Executive Function–Adult Version (BRIEF-A) scores at baseline (n = 24), C4 (n = 18), and 6M (n = 16). RESULTS: Better MMQ scores were significantly correlated with lower interleukin-1β (IL-1β) at baseline, higher tumor necrosis factor alpha-receptor II (TNF-RII) at C4, and higher Interleukin 8 (IL-8) at 6M. In addition, improvements in MMQ results were correlated with decreases in IL-1β from baseline to 6M (p < 0.05 for all). Better BRIEF-A scores were significantly correlated with lower IL-1β at baseline and higher TNF-RII at C4. Improvements in BRIEF-A scores were correlated with increases in TNF-RII from baseline to C4, and with increases in interleukin 6, IL-8, and TNFRII from baseline to 6M (p < 0.05 for all). CONCLUSIONS: Overall, lower serum IL-1β and higher TNF-RII and IL-8 were associated with better self-reported cognitive function in women with breast cancer undergoing chemotherapy. Future research will examine associations of fatty acid biomarkers and cognitive function. FUNDING SOURCES: Ohio State University Stephanie Spielman Breast Cancer Center Kroger Fund.
format Online
Article
Text
id pubmed-9193788
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91937882022-06-14 The Association of Serum Inflammatory Markers and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy Zhang, Zihan Schnell, Patrick Ormiston, Kate Weinhold, Kellie Kopec, Rachel Lustberg, Maryam Orchard, Tonya Curr Dev Nutr Diet and Cancer OBJECTIVES: Chemotherapy-induced neuroinflammation may contribute to cognitive dysfunction. Previously we found that serum omega-3 and omega-6 fatty acids were associated with inflammatory markers in a cohort of 60 women undergoing chemotherapy for breast cancer. The objective of this project was to determine if serum inflammatory markers were correlated with self-reported cognitive assessments in these women. METHODS: Serum samples and data on self-reported cognitive function were collected from 60 women undergoing adjuvant chemotherapy for breast cancer at baseline, the fourth cycle of chemotherapy (C4), and 6 months after chemotherapy (6M). Serum inflammatory markers were analyzed using multiplex enzyme-linked immunoassay. Spearman's rank correlation was used to quantify the association between inflammatory markers and the Multifactorial Memory Questionnaire (MMQ) scores at baseline (n = 25), C4 (n = 18), and 6M (n = 18), as well as the Behavior Rating Inventory of Executive Function–Adult Version (BRIEF-A) scores at baseline (n = 24), C4 (n = 18), and 6M (n = 16). RESULTS: Better MMQ scores were significantly correlated with lower interleukin-1β (IL-1β) at baseline, higher tumor necrosis factor alpha-receptor II (TNF-RII) at C4, and higher Interleukin 8 (IL-8) at 6M. In addition, improvements in MMQ results were correlated with decreases in IL-1β from baseline to 6M (p < 0.05 for all). Better BRIEF-A scores were significantly correlated with lower IL-1β at baseline and higher TNF-RII at C4. Improvements in BRIEF-A scores were correlated with increases in TNF-RII from baseline to C4, and with increases in interleukin 6, IL-8, and TNFRII from baseline to 6M (p < 0.05 for all). CONCLUSIONS: Overall, lower serum IL-1β and higher TNF-RII and IL-8 were associated with better self-reported cognitive function in women with breast cancer undergoing chemotherapy. Future research will examine associations of fatty acid biomarkers and cognitive function. FUNDING SOURCES: Ohio State University Stephanie Spielman Breast Cancer Center Kroger Fund. Oxford University Press 2022-06-14 /pmc/articles/PMC9193788/ http://dx.doi.org/10.1093/cdn/nzac052.025 Text en © The Author 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Diet and Cancer
Zhang, Zihan
Schnell, Patrick
Ormiston, Kate
Weinhold, Kellie
Kopec, Rachel
Lustberg, Maryam
Orchard, Tonya
The Association of Serum Inflammatory Markers and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy
title The Association of Serum Inflammatory Markers and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy
title_full The Association of Serum Inflammatory Markers and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy
title_fullStr The Association of Serum Inflammatory Markers and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy
title_full_unstemmed The Association of Serum Inflammatory Markers and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy
title_short The Association of Serum Inflammatory Markers and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy
title_sort association of serum inflammatory markers and self-reported cognitive outcomes in women with breast cancer undergoing chemotherapy
topic Diet and Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193788/
http://dx.doi.org/10.1093/cdn/nzac052.025
work_keys_str_mv AT zhangzihan theassociationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT schnellpatrick theassociationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT ormistonkate theassociationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT weinholdkellie theassociationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT kopecrachel theassociationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT lustbergmaryam theassociationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT orchardtonya theassociationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT zhangzihan associationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT schnellpatrick associationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT ormistonkate associationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT weinholdkellie associationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT kopecrachel associationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT lustbergmaryam associationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy
AT orchardtonya associationofseruminflammatorymarkersandselfreportedcognitiveoutcomesinwomenwithbreastcancerundergoingchemotherapy